An independent panel including OHSU’s Jeanne-Marie Guise, M.D., MPH, was convened by the National Institutes of Health in March to weigh evidence about how to manage gestational diabetes. The panel (pictured at left) concluded that “despite potential advantages of adopting a new diagnostic approach for gestational diabetes mellitus (GDM), more evidence is needed to ensure that the benefits outweigh the harms. The panel recommended following the current diagnostic approach until further studies are conducted.”
Aaron Caughey, M.D., Ph.D., was an expert speaker during the NIH Consensus Development Conference, during which the evidence evaluated by Dr. Guise and panel members was presented. Dr. Caughey’s presentation was: Economic Implications of Altering Gestational Diabetes Mellitus Diagnostic Criteria.
The Oregonian published articles before and after the conference. According to the latter Associated Press story, Dr. Caughey’s presentation during the conference included a description of how gestational diabetes diagnoses at OHSU doubled after implementing a one-step blood sugar test:
OHSU "decided it's worth trying because even women with mild diabetes could benefit from nutritional counseling that insurance doesn't always cover unless they're diagnosed."
- Dr. Guise is professor of obstetrics and gynecology and public health and preventive medicine, and director of the State Obstetric and Pediatric Research Collaborative
- Dr. Caughey is chair of obstetrics and gynecology, and associate dean for women’s health research and policy